Document is current
Any future updates will be listed below
-
Authors
Seiffert, Anna
Noack, Sebastian
Wingen-Heimann, Sebastian
Puschmann, Julia
Hübner, Nils-Olaf
Krampe, Jonas
Lübbert, Christoph https://orcid.org/0000-0001-6942-5785
-
Funding
Funding for this research was provided by:
Tillotts Pharma
- License Information
-
More Information
Article History
Received: 25 June 2025
Accepted: 17 August 2025
First Online: 1 September 2025
Declarations
:
: Sebastian Noack is employed by Tillotts Pharma GmbH in Germany and Tillotts Pharma AG in Switzerland. Julia Puschmann, Anna Seiffert, and Jonas Krampe are employees of Gesundheitsforen Leipzig GmbH, which is a paid consultant of Tillotts Pharma GmbH for designing the study, carrying out the analyses, and interpreting the results. Sebastian Wingen-Heimann, Nils-Olaf Hübner, and Christoph Lübbert are experts in the field of Clostridioides difficile infections and received an honorarium from Tillotts Pharma GmbH for input on the study design and review of the results.
: This study used aggregated and anonymized health claims data and therefore did not require approval from institutional review boards or ethical committees or informed consent from patients. The study was conducted in accordance with legal and regulatory requirements and research practices described in the “Good Epidemiological Practice guidelines issued by the International Epidemiological Association”.
